ArticleMethods in molecular biology (Clifton, N.J.)2025
Protocols to Assess the Aging of Human Mesenchymal Stem Cells.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mesenchymal stem cells (MSCs) have various characteristic properties such as self-renewal and multilineage differentiation capability, making them promising tools to be used in clinics in therapeutic settings as a cell-based therapy. For MSCs to be used for therapeutic applications, their prolonged expansion in culture is required to provide a sufficient number of cells. During the expansion in culture, MSCs experience only a restricted number of population doublings, and then they enter senescence. Becoming senescent impairs MSCs' proliferation capability, colony-forming efficacy, and ability to differentiate into various lineages and these limit their application in clinics. Thus, monitoring the senescence and aging of MSCs is essential for their use in therapeutic applications. In this chapter, we summarized the protocols to assess the aging of MSCs through senescence-associated β-galactosidase and colony-forming unit assay.
Indexed as
Identifiers
40459839What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.